Cargando…

CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia

BACKGROUND: Converging evidence suggests that inflammatory processes significantly influence brain injury and clinical impairment in ischemic stroke. Although early studies suggested a key role of lymphocytes, recent data has emphasized the orchestrating function of innate immunity, i.e., macrophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Choe, Chi-un, Lardong, Kerstin, Gelderblom, Mathias, Ludewig, Peter, Leypoldt, Frank, Koch-Nolte, Friedrich, Gerloff, Christian, Magnus, Tim
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097994/
https://www.ncbi.nlm.nih.gov/pubmed/21625615
http://dx.doi.org/10.1371/journal.pone.0019046
_version_ 1782203903382650880
author Choe, Chi-un
Lardong, Kerstin
Gelderblom, Mathias
Ludewig, Peter
Leypoldt, Frank
Koch-Nolte, Friedrich
Gerloff, Christian
Magnus, Tim
author_facet Choe, Chi-un
Lardong, Kerstin
Gelderblom, Mathias
Ludewig, Peter
Leypoldt, Frank
Koch-Nolte, Friedrich
Gerloff, Christian
Magnus, Tim
author_sort Choe, Chi-un
collection PubMed
description BACKGROUND: Converging evidence suggests that inflammatory processes significantly influence brain injury and clinical impairment in ischemic stroke. Although early studies suggested a key role of lymphocytes, recent data has emphasized the orchestrating function of innate immunity, i.e., macrophages and microglia. The bifunctional receptor and ectoenzyme CD38 synthesizes calcium-mobilizing second messengers (e.g., cyclic ADP-ribose), which have been shown to be necessary for activation and migration of myeloid immune cells. Therefore, we investigated the dynamics of CD38 in stroke and the impact of CD38-deficiency on cytokine production, inflammation and cerebral damage in a mouse model of cerebral ischemia-reperfusion. METHODOLOGY/PRINCIPAL FINDINGS: We show that the local expression of the chemokine MCP-1 was attenuated in CD38-deficient mice compared with wildtype mice after focal cerebral ischemia and reperfusion. In contrast, no significant induction of MCP-1 expression was observed in peripheral blood after 6 hours. Flow cytometry analysis revealed less infiltrating macrophages and lymphocytes in the ischemic hemisphere of CD38-deficient mice, whereas the amount of resident microglia was unaltered. An up-regulation of CD38 expression was observed in macrophages and CD8(+) cells after focal cerebral ischemia in wildtype mice, whereas CD38 expression was unchanged in microglia. Finally, we demonstrate that CD38-deficiency decreases the cerebral ischemic injury and the persistent neurological deficit after three days of reperfusion in this murine temporary middle cerebral artery occlusion (tMCAO) model. CONCLUSION/SIGNIFICANCE: CD38 is differentially regulated following stroke and its deficiency attenuates the postischemic chemokine production, the immune cell infiltration and the cerebral injury after temporary ischemia and reperfusion. Therefore CD38 might prove a therapeutic target in ischemic stroke.
format Text
id pubmed-3097994
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30979942011-05-27 CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia Choe, Chi-un Lardong, Kerstin Gelderblom, Mathias Ludewig, Peter Leypoldt, Frank Koch-Nolte, Friedrich Gerloff, Christian Magnus, Tim PLoS One Research Article BACKGROUND: Converging evidence suggests that inflammatory processes significantly influence brain injury and clinical impairment in ischemic stroke. Although early studies suggested a key role of lymphocytes, recent data has emphasized the orchestrating function of innate immunity, i.e., macrophages and microglia. The bifunctional receptor and ectoenzyme CD38 synthesizes calcium-mobilizing second messengers (e.g., cyclic ADP-ribose), which have been shown to be necessary for activation and migration of myeloid immune cells. Therefore, we investigated the dynamics of CD38 in stroke and the impact of CD38-deficiency on cytokine production, inflammation and cerebral damage in a mouse model of cerebral ischemia-reperfusion. METHODOLOGY/PRINCIPAL FINDINGS: We show that the local expression of the chemokine MCP-1 was attenuated in CD38-deficient mice compared with wildtype mice after focal cerebral ischemia and reperfusion. In contrast, no significant induction of MCP-1 expression was observed in peripheral blood after 6 hours. Flow cytometry analysis revealed less infiltrating macrophages and lymphocytes in the ischemic hemisphere of CD38-deficient mice, whereas the amount of resident microglia was unaltered. An up-regulation of CD38 expression was observed in macrophages and CD8(+) cells after focal cerebral ischemia in wildtype mice, whereas CD38 expression was unchanged in microglia. Finally, we demonstrate that CD38-deficiency decreases the cerebral ischemic injury and the persistent neurological deficit after three days of reperfusion in this murine temporary middle cerebral artery occlusion (tMCAO) model. CONCLUSION/SIGNIFICANCE: CD38 is differentially regulated following stroke and its deficiency attenuates the postischemic chemokine production, the immune cell infiltration and the cerebral injury after temporary ischemia and reperfusion. Therefore CD38 might prove a therapeutic target in ischemic stroke. Public Library of Science 2011-05-13 /pmc/articles/PMC3097994/ /pubmed/21625615 http://dx.doi.org/10.1371/journal.pone.0019046 Text en Choe et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Choe, Chi-un
Lardong, Kerstin
Gelderblom, Mathias
Ludewig, Peter
Leypoldt, Frank
Koch-Nolte, Friedrich
Gerloff, Christian
Magnus, Tim
CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
title CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
title_full CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
title_fullStr CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
title_full_unstemmed CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
title_short CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia
title_sort cd38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097994/
https://www.ncbi.nlm.nih.gov/pubmed/21625615
http://dx.doi.org/10.1371/journal.pone.0019046
work_keys_str_mv AT choechiun cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT lardongkerstin cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT gelderblommathias cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT ludewigpeter cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT leypoldtfrank cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT kochnoltefriedrich cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT gerloffchristian cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia
AT magnustim cd38exacerbatesfocalcytokineproductionpostischemicinflammationandbraininjuryafterfocalcerebralischemia